150 related articles for article (PubMed ID: 11559886)
1. The clinical efficacy of higher hematocrit levels in children with chronic renal insufficiency and those undergoing dialysis.
Yorgin PD; Belson A; Al-Uzri AY; Alexander SR
Semin Nephrol; 2001 Sep; 21(5):451-62. PubMed ID: 11559886
[TBL] [Abstract][Full Text] [Related]
2. Trends in anemia treatment with erythropoietin usage and patient outcomes.
Collins AJ; Ma JZ; Xia A; Ebben J
Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S133-41. PubMed ID: 9892380
[TBL] [Abstract][Full Text] [Related]
3. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
Nissenson AR
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
[TBL] [Abstract][Full Text] [Related]
4. Low-dose recombinant human erythropoietin therapy in chronic hemodialysis patients.
Duff DR; Golper TA; Sloan RS; Brier ME; Aronoff GR
Am J Kidney Dis; 1991 Jul; 18(1):60-4. PubMed ID: 2063856
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin therapy in chronic uremia: the impact of normalization of hematocrit.
Murphy ST; Parfrey PS
Curr Opin Nephrol Hypertens; 1999 Sep; 8(5):573-8. PubMed ID: 10541220
[TBL] [Abstract][Full Text] [Related]
6. Dialysis dose, membrane type, and anemia control.
Young EW
Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S157-60. PubMed ID: 9892384
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperparathyroidism on response to erythropoietin in children on dialysis.
Belsha CW; Berry PL
Pediatr Nephrol; 1998 May; 12(4):298-303. PubMed ID: 9655362
[TBL] [Abstract][Full Text] [Related]
8. The intensity of hemodialysis and the response to erythropoietin in patients with end-stage renal disease.
Ifudu O; Feldman J; Friedman EA
N Engl J Med; 1996 Feb; 334(7):420-5. PubMed ID: 8552143
[TBL] [Abstract][Full Text] [Related]
9. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
10. The treatment of anemia with low-dose recombinant human erythropoietin.
Aronoff GR; Duff DR; Sloan RS; Brier ME; Maurice B; Erickson B; Golper TA
Am J Nephrol; 1990; 10 Suppl 2():40-3. PubMed ID: 2260617
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
Sobota JT
Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
[No Abstract] [Full Text] [Related]
12. Role of blood rheology in the pathogenesis of hypertension of hemodialysis patients treated for renal anemia with recombinant human erythropoietin.
Baldamus CA; Steffen AM; Brunner R; Pollok M
Contrib Nephrol; 1990; 82():79-85. PubMed ID: 2093531
[No Abstract] [Full Text] [Related]
13. Anemia management in patients with chronic renal insufficiency.
Kausz AT; Obrador GT; Pereira BJ
Am J Kidney Dis; 2000 Dec; 36(6 Suppl 3):S39-51. PubMed ID: 11118157
[TBL] [Abstract][Full Text] [Related]
14. Evidence-based systematic literature review of hemoglobin/hematocrit and all-cause mortality in dialysis patients.
Volkova N; Arab L
Am J Kidney Dis; 2006 Jan; 47(1):24-36. PubMed ID: 16377382
[TBL] [Abstract][Full Text] [Related]
15. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial.
Eschbach JW; Egrie JC; Downing MR; Browne JK; Adamson JW
N Engl J Med; 1987 Jan; 316(2):73-8. PubMed ID: 3537801
[TBL] [Abstract][Full Text] [Related]
16. Impact of erythropoietin on the dialysis prescription.
Van Wyck DB
Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):71-5. PubMed ID: 1928083
[TBL] [Abstract][Full Text] [Related]
17. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
[TBL] [Abstract][Full Text] [Related]
18. [Human recombinant erythropoietin (rH-EPO) in chronic hemodialysis patients].
Jalil R; Vaccarezza A; Jara A; Lira P; Vial S; Serrano V
Rev Med Chil; 1990 Jun; 118(6):629-34. PubMed ID: 1775783
[TBL] [Abstract][Full Text] [Related]
19. Effects of erythropoietin in predialysis patients.
Anderson S
Am J Kidney Dis; 1991 May; 17(5 Suppl 1):103-6. PubMed ID: 2024665
[No Abstract] [Full Text] [Related]
20. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]